My father was a heart surgeon doing cardiac research with the US Navy. My maternal grandfather was a physician and the commanding naval offi cer of the hospital at the time. (Not many newborns were delivered at the hospital because there weren't many women in the navy then.) We lived in the Washington, DC, area for 2 years and then moved to Boston, where my father fi nished his surgical training at the Massachusetts General Hospital and my mother fi nished her master's degree in education at Harvard University (Figure 2) . We moved to Dallas in 1963 and lived in the Park Cities for a few years. I went to St. Mark's School, graduating in 1977, and then to Princeton University, majoring in neuropsychology and doing research in neuroanatomy, utilizing stereotaxic surgery in the hypothalamus. I returned to Dallas for medical school at the University of Texas (UT) Southwestern Medical School, graduating in 1986. I was planning to be a cardiothoracic surgeon like my father, but after a medical school rotation in surgery at the Massachusetts General Hospital, I realized that wasn't the right fi eld for me for a variety of reasons. I really wanted to get into a growing fi eld. At that time, the mid 1980s, magnetic resonance imaging (MRI) had just come into use. (Computed tomography [CT] was invented in the mid 1970s.) For the fi rst time, technology was available
I decided to go into psychiatry and trained at Parkland Hospital, the Veterans Administration Hospital, and Presbyterian Hospital in Dallas for 3 years. I had a fabulous mentor, John Rush, who was world famous in depression research. After being exposed to a lot of patients with alcohol and drug addiction, I realized that I liked working with that population. Dr. Rush suggested that I do a 2-year clinical research fellowship at the University of Pennsylvania in Philadelphia, and I was accepted at that program, which was one of the top four addiction treatment fellowship training sites in the USA at the time. I was there from 1989 to 1991, fi nishing my last year of psychiatry residency there and at the same time doing the fi rst year of the 2-year clinical research fellowship in addiction psychiatry. I had incredible mentors in addiction psychiatry there: Charles O 'Brien, MD, PhD, Th omas McLellan, PhD, and George Woody, MD. Th eir research/academic training center was amazing. Th e only other strong addiction training centers at that time were at Harvard, the University of California at Los Angeles (UCLA), and Yale. While doing the addiction training, I also worked with Timothy Beck, MD, who invented cognitive therapy, the gold standard of most psychiatric therapy today. Th us, I came away from the University of Pennsylvania with training in both addiction psychiatry and cognitive therapy.
Returning to Dallas in 1991, I worked for 3 years in a psychiatric staff -model clinic run by one physician. (Th is was the early days of capitation and managed care.) We serviced a large Aetna population within Baylor University Medical Center as a private "carved-out" mental health and addiction treatment program. I worked in that model trying to put together a comprehensive, science-based addiction treatment approach similar to what I had learned at Penn. During that time I came in contact with another great mentor, Walter Ling, MD, PhD, who was a board-certifi ed neurologist and psychiatrist at UCLA. Th e two of us and Dr. Th omas McLellan worked together to formulate a standardized addiction protocol to treat outpatients with a high level of consistency. We were desirous of delivering high-quality, science-based care for addiction across the country.
I had always wanted to go to business school, and I realized that to take this standardized addiction protocol to a practical level, business school would be useful. Th us, after 3 years of practice, I enrolled in the Stanford Graduate School of Business in Palo Alto, California, on a Sloan Fellowship, a 1-year program for a master's in management administration, an advanced version of the traditional MBA. Classes were with senior-level managers from companies all over the world. It was a great exposure on multiple levels to business in general as well as the business of health care.
After graduating from Stanford University and observing so many changes in health care, I decided that instead of reentering my medical practice, I wanted to form a multispecialty physician practice management company. At the time in 1995, businessmen were "buying up" physician offi ces in similar specialties and rolling them into large groups. Th e idea essentially was to make the backoffi ce functions more effi cient, thereby allowing physicians to focus more on their patients. Most of the groups that were formed didn't do well because the physicians did not own the companies. (Physicians are pretty independent animals.) Certain specialties tended to be successful, and a few of the groups are still around, such as Pinnacle, the big anesthesia group; Pediatrix, a pediatric intensive care group; and EmCare, an emergency physician group.
I tried to start a physician-owned group and created Aegis Healthcare. Although physicians owned the company, business people ran it. Th e physicians had the major ownership stake so they could feel in control. It worked. Clinical care was always of high quality. (Th at was not happening many times when the businessmen owned the companies.) Aegis Healthcare was a multispecialty group practice statewide. Aegis did well for about 3 years and then the physician practice management concept started to implode. Although the model was correct, momentum ceased and we broke up the company.
I then decided to go back into private practice in 1998. During the 4 years I was out of practice in business school and then trying to help physicians retain control of the quality of health care delivery, I was contacted on numerous occasions by physicians about referrals for their own or their family members' addictions. Unfortunately, only a handful of physicians in Dallas had been formally trained in addiction psychiatry, so I had a diffi cult time referring them to a treatment program with a good sciencebased approach. Consequently, I felt "called back" into the addiction treatment fi eld, because I had been given clinically excellent training and I had a good business plan on how to implement it for the benefi t of many patients and their families.
In 1999, I went into practice at St. Paul University Hospital and tried to put into practice the business plan I created at Stanford. I put together a science-based multitiered alcohol and drug treatment program that had both inpatient and outpatient components and a comprehensive, science-based approach to addiction. It Urschel: Yes. We had family dinners every night. We were a really close family. To my father's credit, being a heart surgeon, he was usually home between 5:30 and 7:00 pm every day. He was very supportive of our sporting events. Our mother was the greatest homemaker. I don't know how she was able to do such a great job with fi ve kids. We had a very well-balanced and positive environment. In addition to my wonderful family, I had great peers in my class at St. Mark's. Th ose positive relationships are so critical to creating healthy choices growing up.
Roberts: What were dinners like at your house when growing up?
Urschel: With seven people at the table, we would take bets on who would spill their drink at that particular meal. It was a very busy environment. Also, we were all strong talkers. Th ere is 13 years between my youngest sister, Susanna, and me, so we always had a young contingent. Conversations revolved around school and family. It wasn't easy to get a word in, but it wasn't just because my father monopolized the conversation; we were all just as guilty. A psychiatrist is supposed to "listen." Not speaking is the thing I struggle with the most.
Roberts: I am very fond of both of your parents. At Princeton you were already interested in the brain?
Urschel: Other than premed, I didn't know what I wanted to major in at Princeton. I was just excited to be there. I had to work really hard, especially during the football season. I loved the liberal arts component of Princeton. Th ey did not have any major graduate schools (i.e., no medical school, law school, or business school), so the undergraduates were able to get all of the great professors. A psychiatry course and a couple of brain physiology courses interested me during my fi rst couple of years.
At that time, I planned on going to medical school to become a surgeon ( Figure 5 ). After my junior year, I did a summer internship with a professor at UT Southwestern Medical School who was doing brain and heart surgery on dogs. I assisted him with stereotaxic brain surgery to research the brain's eff ect on the heart relating to stressful situations. For my senior-year thesis at Princeton under the guidance of Professor Bart Hoebel, PhD, I then did a neuropsychology surgical study on rats to determine naltrexone's eff ect when injected in the hypothalamus, the brain area thought to control appetite, and then compared the appetites of the study rats to those of the placebo rats. What is so interesting is that this medication is now approved by the Food and Drug Administration to treat alcohol and opiate addiction, and I use it almost every day with my patients. It is amazing how God seems to always be planting seeds to help you have the tools to achieve his plans for your life.
Roberts: What was the number of students at Princeton when you were there?
Urschel: About 5000 total, with 1200 in each class. Urschel: I was comfortable because I was back in Dallas and we had a great class of students in my year. Th ere were some signifi cant surprises, however, as I had rarely taken standardized tests. At St. Mark's and Princeton, all tests were essay types. Consequently, because all of the tests at UT Southwestern were standardized, if you knew 9 of 10 facts about a subject but missed the 10th, you received a zero on that question rather than a 90. I did poorly the fi rst quarter of my freshman year in medical school, and it scared the pants off of me because I was studying the same way I had done in the past. However, I had great classmates who really helped me evolve to the more traditional testing environment. Also, Brian Williams was the dean of student aff airs at the time, and he was a great mentor and support.
Roberts: At Princeton you graduated cum laude. What does that mean?
Roberts Urschel: My father, having trained there, paired me with a brilliant heart surgeon, Ashley Moncure. Dr. Moncure had been an intern when my father was chief resident on the surgical service. Th ey bonded, and now he is a giant in the cardiothoracic fi eld at Massachusetts General Hospital. During my externship, we were doing many types of surgery. He had an enormous referral service. Sometimes in his offi ce, 12 aortic aneurysm patients would be lined up to see him in one afternoon. What changed my mind about being a surgeon was that Dr. Moncure allowed me a lot of surgical experiences, but the actual surgeries just didn't excite me.
I returned to Southwestern in the fall of 1985 with the thought of doing something else. I was still fascinated with the brain after my neuropsychology work at Princeton. Th ere were three ways back then to enter the fi eld of brain science: neurosurgery, neurology, and psychiatry. Neurosurgery was still surgery. Neurology at the time was mainly diagnostic, had little therapeutics, and focused mostly on peripheral neuropathies and muscle issues. Th at left me psychiatry.
I did my fi rst 2-month psychiatry rotation in Dallas at the Veterans Aff airs Hospital. Before that experience, I hadn't seen a bipolar disorder or true depression or true schizophrenia. A few medicines were available that really made a diff erence, but in the early 1980s psychiatry was still Freudian driven, because not much was known about the brain. I saw that situation as an attractive opportunity. I saw how lithium signifi cantly helped some of these very sick patients within a matter of days. Seeing what happened when patients were given medications that worked on the brain-almost like a scalpel in surgery in terms of speed and eff ectiveness-impressed me. When their neurochemicals were out of bounds and they were having psychotic breaks, it was disconcerting to be around these psychiatric patients, but once they got better, they were really nice people. Understanding the opportunity of being able to grow with the fi eld of brain science was what really convinced me to go into psychiatry. By that time it was late in the match process, but UT Southwestern and Ken Altschuler, MD, chairman of psychiatry (for about 15 years), provided a position for me. Psychiatry is a 4-year residency. I did 3 years at Southwestern and 1 year at the University of Pennsylvania.
Roberts: Once you had started the residency in psychiatry, did you feel good about your decision to go into this specialty?
Urschel: Yes. I really enjoyed it. Roberts: Were there any surprises during residency? Urschel: Usually only enjoyable surprises, such as I liked working in the psychiatric emergency room at Parkland Hospital, because it was fast moving and had sort of an adrenaline rush. Th at's where I saw the really signifi cantly stressed individuals (suicidal, psychotic, manic, or intoxicated) and how the medications could make a diff erence in people's lives very quickly. Th e biggest surprise for me was that I liked working with patients with alcohol and drug addiction, because once they got sober they were completely normal people.
In the mid 1980s there was a psychiatric hospital on every corner. It was a huge money-making operation for those companies. Th ere were a lot of opportunities to moonlight, which I often did, to see how it was to work in the private-practice environment. Back then only a very few had special training in addiction. Dr. Rush, my mentor, suggested that I needed more formal training in my fi eld of intended specialization. We discussed fellowships in addiction. I chose the University of Pennsylvania training fellowship because I thought it was the strongest program, as it had the combination of the talents of Drs. O'Brien, McLellan, and Woody, each of whom brought diff erent attributes to the program. Th ey had worked together for about 20 years and had created an excellent training infrastructure combining education, research, and treatment. It was a very rich, warm, and supportive environment that was intellectually very stimulating.
Roberts: Were you married by that time? Urschel: I was married during my internship in psychiatry in 1986. I was 28.
Roberts: What were some features of Christi that attracted you to her?
Urschel: She is beautiful, bright, and athletic. We clicked from the very beginning. I saw her across the court at a Dallas Mavericks game and out of the blue went over and introduced myself, something I never do. Four months later we were engaged, and in another 6 months we were married. She is a wonderful person. She has a great spiritual, Christian focus. She is the kind of person that makes you a better person by being around her. My parents were like that as well when I was growing up.
Roberts: Do you have children?
Urschel: Yes, we have two children ( Figure 6 ). Our oldest son is Chance. He is 15.
Roberts: What is his real name?
Urschel: Carter Chancellor Urschel. Our other son is Bradley Carrington Urschel, and he is 10 years old.
Roberts: What are they like?
Urschel: Chance has a neurological birth defect called holoprosencephaly (HPE). Physically he presents as cerebral palsy, but that is only a wastebasket diagnosis that means the cause is unknown. Holoprosencephaly is a neurological birth defect where the frontal lobes are fused. Th e back part of his brain is normal. Th e front part controls a lot of the motor systems, so he can't walk or talk or sit up on his own, but he is intelligent and bilingual. He's never been able to say a word.
His illness, which occurred before birth, was very traumatic for us, since not much was known about this birth defect at the time. Consequently, we put together a multisite research initiative called the Carter Centers for Brain Research in HPE and Related Malformations. Its purpose is to explore the causes and clinical syndrome of these defects. Th e Carter Centers started when the then chairman of the neurology department at Children's Medical Center told us that Chance wouldn't live longer than a year and wouldn't amount to much, so we shouldn't get our hopes up. Th at advice didn't sit well with us. My parents started calling around and found the best clinicians in pediatric neurology in the country. We went to visit them all and got them excited and pulled them together to work on HPE.
Th e Carter Centers comprise a group of high-powered researchers at six main sites: Texas Scottish Rite Hospital, Stanford University/University of Southern California, Johns Hopkins, Harvard, the University of Toronto, and the University of Birmingham (Alabama). We encouraged them to work together to create a virtual research center of excellence. We have also engaged several of the relevant pediatric-focused institutes at the National Institutes of Health (NIH) to help us, and they are very excited to be able to work with our research team members.
We have funded the Carter Centers through some foundations in Christi's family as well as other charitable organizations here in Dallas. We set up a great cutting-edge neuroscience research team to focus on fi nding new treatments for Chance's neurological birth defect, and we acted as the catalyst both fi nancially and educationally.
HPE is more common that Huntington's disease. Currently, we have an international database of children with HPE, and we are doing genetic and neuroradiological studies and have even found some eff ective treatments for some of the symptoms. In 2011, 15 years later, a comprehensive website provides much information about the neurological condition and its treatments and creates hope for the families who are just now beginning their journeys.
As the Carter Centers' research progressed, we found that almost all the HPE kids have motor problems, so that discovery was spun off into another multisite research initiative called the Chance Institute for Motor Solutions, which is a subgroup within those universities and others that focuses on looking for new treatments for children who can't move or communicate. (Talking is a motor function with 144 diff erent muscles in the tongue and vocal cords that have to function perfectly to make sounds.) Chance is always trying to talk, making sounds, but his tongue and vocal cords can't work right. Th e Chance Institute for Motor Solutions has 14 centers around the country, and the NIH is now funding almost the entire initiative.
Roberts: What about your other son?
Urschel: Carr is a healthy 10-year-old attending St. Mark's School of Texas.
Roberts: What does he want to do? Urschel: He says that he is going to play for the Mavericks one day and become a National Basketball Association star. I honestly don't know what he is going to do, but I do know that he loves his older brother very much.
Roberts: How do you take care of Chance? Urschel: We have been blessed with the fi nancial resources to have a couple of nannies/assistants to be able to help us at home with him. He is in a wheelchair, and we have to give physical therapy every day. Most recently we have been focused on evaluating diff erent communication technologies, including some of the eye-gaze systems. He has been home-schooled now for about 3 years. We have someone with him 12 hours a day and he sleeps great, so we handle him by ourselves at night.
Roberts: Could you talk about your endeavor in treating addiction?
Urschel: It's important that people understand that alcoholism and drug addiction are both diseases; in fact, they are chronic medical diseases of the brain.
Roberts: Of those two addictions, alcohol is a much greater problem than drugs.
Urschel: Yes. It would be necessary to multiply the diff erent types of drug addictions combined-prescription medications, marijuana, heroin, cocaine-by 10 to get the number of alcoholics in our country.
Roberts: How do you defi ne alcoholism?
Urschel: Alcoholism is a chronic medical disease of the brain. To diagnose it, you have to meet 3 of 7 diagnostic criteria. Th ere isn't a blood test or brain scan to diagnose alcoholism. Th ere will be in about 5 years, hopefully. You can tell someone is an alcoholic if they continue to use alcohol despite its leading to negative consequences.
One criterion is tolerance. Tolerance is a neurological brain receptor adaptation response. When the substance is pulled away, the adaptation imbalance is what causes the withdrawal. Sometimes addiction occurs without tolerance, such as with a weekend addict where the body has 4 days to recover from the 3 days of consuming alcohol. Usually tolerance comes from using the drug daily. Again, alcoholism is present when individuals continue to use the substance despite its causing signifi cant problems in any part of their life-work, marriage, legal, friends, physical-even if they don't have tolerance or withdrawal.
Another criterion is loss of control. Alcoholics can't just have one drink a night. Th ey almost always have more than they intend, no matter how often they drink. Th at is a brain issue, not a matter of willpower. Once you have the disease, the brain kicks in. Th ink of it like trying to lose 10 pounds: you've been sticking with the diet for 3 weeks and then open the freezer and see that pint of Ben & Jerry's. You say to yourself, "I will only have one spoonful, since I've been really good for 3 weeks." You have the one spoonful and what happens? You eat the whole thing. Eating that fi rst spoonful triggers a response in your brain. Now multiply that natural trigger by 1000, and that is what addicts have to contend with when they try to drink only one drink. Several important parts of the brain are injured or damaged in those who have the disease of alcohol or drug addiction (Figure 7 ). Th at injured brain area is activated by the triggers (cues) in the environment, producing an overwhelming physiological response requiring the alcoholic to plunge into drinking excessively again, after that fi rst drink is consumed.
Roberts: We have nearly 310 million people in the USA, probably 270 million or so >15 years of age. How many alcoholics do we have in the USA?
Urschel: I think the number of alcoholics in the US is underreported, but a good estimate is 8 to 12 million, or about 7% to 9% of the population. Th e frequency is estimated by sampling and self-reporting. More importantly, alcoholism is the third leading cause of death in the USA behind heart disease and cancer, killing over 100,000 Americans each year. Alcoholism is a life-threatening illness, a chronic medical disease of the brain that we are not treating at all in many areas of our country.
Roberts: Does being an alcoholic have to do with the quantity of alcohol a person drinks?
Urschel: Great question. All use of alcohol injures the brain to some extent. If you were out camping and cut yourself and didn't have a fi rst-aid kit but did have a bottle of Jack Daniels, you could pour that Jack Daniels on the wound after it stopped bleeding to kill the bacteria and to anesthetize the cut, correct? Th at same substance, when you put it in the brain, kills brain cells. Th e more alcohol consumed, the more brain cells that are killed. Also, that same substance kills cells in the esophagus, liver, bones, blood system, and pancreas, just to name a few of the myriad organ systems to which alcohol is toxic.
So, alcohol quantity and duration of use are factors but there is another factor-genes. Because this is a chronic medical disease, it has about a 50% direct genetic link. What that means is if direct blood relatives are addicted, you have a 45% to 50% chance of being addicted yourself. If you don't have alcoholism in your family tree, it usually takes 5 to 7 years of pretty heavy drinking to damage specifi c areas of the brain enough to develop the disease, because the body is so resilient. (For example, to need a liver transplantation, you have to kill about 70% of the liver before it won't regenerate. Once you are down to about 35% of the liver left, then you are a candidate for a liver transplant.) Th at's without genetic loading. If you have genetic loading, you might be more susceptible to the injury, so maybe in only 2 or 3 years of heavy drinking you might become an alcoholic. In other words, addiction has both an environmental and a genetic component, just like with many other chronic medical diseases.
Roberts Urschel: I know that this issue causes a lot of angst at times. From a science standpoint, limiting the drinking age to 21 is a godsend. Th at age requirement keeps some people from drinking until age 21, protecting those young people from getting our third leading cause of death. It's a real conundrum. Don't look at alcohol as a right; look at alcohol drinking as a punishment or a danger, as toxic as smoking cigarettes. I frequently ask people, "We know so much about the negative eff ects of cigarette smoking, so knowing what we know now, if cigarettes were illegal today, would you make them legal?" Roberts: Absolutely not. Urschel: We should have the exact same answer for alcohol. We know so much about alcohol-it is a poison, it is the third leading cause of death in the USA-so the fact that you cannot drink alcohol until age 21 is protective and cost saving. Nondrinking behavior prevents drunk driving with its multiple hazards, lowers health care costs, and protects the brain from IQ loss. I strongly recommend to my son Carr that he doesn't drink until he is 21. We talk about the dangers of alcohol and drugs a lot.
Roberts: I must be naïve, but I hadn't heard this business about alcohol's special toxicity when one starts drinking at a young age.
Urschel: Between ages 15 and 23 years, the brain grows at an exponential rate and therefore is more susceptible to injury than older (mature) brains. Th at's why you can learn so much in college and then a couple of years later it's hard to learn as rapidly. If I tried to go to medical school now, it would be harder for me to learn compared to the young ones who are there. Th e brain is not just creating a few cells but creating massive neural networks on multiple levels that are connecting all over the system. Th is complex and important network creation is very susceptible to injury from alcohol and drugs.
Roberts: Is it true that the weight of the brain at age 15 is probably about the same weight as at age 23? Urschel: I know the weight would be less at age 15 than at age 23, but I don't know how much less. Although I am not a neuroanatomist, the cerebral cortex grows outward, so we lay down the outer layers of cortex, which have the highest intellect and abstract function systems, last. Th at's why, for instance, calculus is not taught to 13-year-olds, in general, because their brain's abstract ability is not there yet. Th ey are still more at the concrete-thinking level.
Roberts: How was the average alcoholic treated in 2004?
Urschel: Sadly, the same way they were treated in 1950, in 1970, and today.
Roberts: What is "average" or the typical treatment for an alcoholic today?
Urschel: Alcoholics are referred to the 12-step program of Alcoholics Anonymous (AA), sometimes to a counselor for individual counseling, but usually just to AA for treatment of their "condition." About 20% of alcoholics are referred only to churches. Th ey are told to go to church and pray about how not to take the next drink. However, the advice given by most people in the country-physicians, ministers, judges, and treatment programs-is to go to an AA meeting. Th at's why I wrote Healing the Addicted Brain (Figure 8 ). Th at's why we created Enterhealth, to give critical, science-based information about how to successfully treat alcohol/drug addiction to the general public.
Th e current system of addiction treatment has to change. It's not nearly as eff ective as it could be. It's antiquated. We are using the same technology that was used back in 1940 to treat 85% to 90% of the alcoholics and drug addicts in the USA, and that is bad news if the addicted person is someone that you love or care about. In this and the last decade, science-based treatments and understanding of the disease have appeared. I do not want to bash the 12-step AA approach, but so much more is available in addition to AA and Narcotics Anonymous.
Roberts: Th e 12 steps are the AA's principles? Urschel: Yes. When Bill Wilson created them, he never intended for them to be treatment. He intended them to be a supportive fellowship to help people stay sober. At the time, we had zero treatment for alcoholism, and research shows that about 20% to 25% of the people who go only to AA can stay sober long term (years). If you look at just months, the sobriety success rate for AA is a lot higher than 20%. Remember that this is a chronic medical disease. Because the disease is so life threatening, alcoholics see a 20% long-term success rate as pretty good, particularly if they are not off ered other treatments. However, for physicians, a 20% success rate means that 80% of their patients fail therapy and die. In general, physicians have had no training in any of the new treatments based on the science of addiction, so most think that they can send patients only to AA.
Referring alcoholics to AA gets them "out of your hair," because they require a lot of a time in terms of phone calls and offi ce visits. Physicians might notice that a patient's blood sugar or blood pressure has risen and ask if he or she is still drinking. Most physicians do not dig deeper, because they usually have only 10 to 15 minutes per patient. Physicians believe that they can't focus on this disease if there isn't an eff ective treatment for it-and a 20% success rate to a physician is not eff ective. It's a subconscious thing, and resources are scarce. As a consequence, few physicians get energized to learn about and treat this disease.
Roberts: What questions do you ask patients to fi gure out whether or not they are an alcoholic or drug addict?
Urschel: Th ere are four questions called CAGE: 1) Has anyone else ever encouraged you to cut back on your drinking/ drug use? 2) Do other people annoy you by complaining about or asking about your drinking/drug use? 3) Have you ever felt guilty about your drinking/drug use? and 4) Do you ever need an eye-opener just to start the day?
If a patient answers yes to any one question, there is an 85% chance he or she is an alcohol/drug addict; a yes to two questions is a 90% chance. Th ese four questions need to be posted in every physician's waiting room or put on new patient intake forms along with encouragements to discontinue cigarettes. Th e four questions need to be a part of the "vital signs" of all patients. A patient who answers yes to any of these questions needs to be treated or referred to an addiction treatment specialist. Th ere is no reason or excuse not to look for alcohol/drug addiction routinely in patients today, because if identifi ed, so much can be done to help them achieve sobriety.
Health care reform is a huge potential threat to physicians for a variety of reasons. On a national level, addiction treatment will not be included in any eff ective way. Yet, alcohol and drug addiction in 2008 cost America over $500 billion. A lot of that cost is lost work productivity due to death associated with alcoholism. I believe that there is a lot of money in the system. If alcoholism and drug addiction were treated eff ectively, there would be a huge surplus of available funds because treating the medical conditions that occur after someone becomes an alcoholic is 12 times more expensive than preventing these conditions from occurring. It might cost $5000 to get an alcoholic sober with medications and $250,000 to do a liver transplant. Also, the emergency department/intensive care unit/trauma-related costs for addiction are huge. Active alcohol/drug use negatively impacts the treatment for other chronic medical diseases, such as cardiac disease, diabetes, and hypertension, in terms of medication compliance, diet, and activity. Th e medical cost consequences of loss of diabetic control, hypertensive control, or cardiac control are astronomical. Th e Robert Wood Johnson Foundation has found that for every dollar invested in eff ective alcohol/drug addiction treatment, $7 to $12 is returned to society. Th e money is there; we just have to treat addiction eff ectively.
Roberts: When you say alcohol is the third leading cause of death in the USA, you mean that if someone is drinking and causes a fatal accident it will be considered an alcohol-related death?
Urschel: Yes. Alcoholism kills over 100,000 Americans a year. Let me put that number in perspective. In the fi rst 6 years of the Iraq war, we lost 5000 US men and women. During that same time, we lost over 600,000 Americans to alcoholism.
Roberts: If they have a liver transplant because of portal cirrhosis and they die, is it an alcohol-related death? Th ere are a variety of deaths that come under the umbrella of alcohol.
Urschel: Yes. Alcohol-related deaths can be due to alcohol poisoning or to alcohol impairment of a variety of organs. Alcoholism is the third or fourth leading cause of gastrointestinal cancer because of the alcohol-stimulating carcinogens. A glass of wine at night is now considered "good medicine" for a longer life, and alcohol-producing companies spend billions of dollars a year promoting alcohol as fun and not dangerous. Our guard has dropped.
Roberts: Let's say that someone answered yes to two questions and came to your center. What is going to happen?
Urschel: He will get an assessment by phone to see how serious his symptoms are. Most people (70%) need outpatient evaluations. When the patient comes into the offi ce, he will see a medical provider (psychiatrist or nurse practitioner) and get a complete addiction psychiatric history. Time is spent assessing whether he is an alcohol/drug addict or not. Let's just assume that he is an alcoholic, wants help, and can be treated as an outpatient. We then create an individualized treatment plan. Th ere are multiple types of alcoholism, and a personalized treatment plan will be more likely to allow him to achieve long-term sobriety. Th is plan will encompass a comprehensive model (Figure 9 ).
What the NIH has found after spending $1 to $2 billion on research on addiction is that the way to treat this disease is by using a comprehensive approach, a combination of diff erent treatment components that include antiaddiction medications that actually go to the brain to address the disease of addiction. We then assess if there is a psychiatric component: depression, anxiety, or manic depression. A lot of times when the brain is injured from alcohol, other parts of the brain are also injured. Treating only the alcohol piece is not enough. If depression is present, the low energy and low motivation will make it hard to follow the personalized treatment plan, so in addition to antiaddiction medicines, psychiatric treatment and counseling are usually critical for success. Additionally, wellness and nutrition-a specifi c program of healthy exercise and nutrition-is a very important component, because the alcoholic's body and brain are injured, so the right building blocks to accelerate these healing process are essential. Th e other part of the wellness nutrition program is stress management, because many of the wellness components (i.e., several kinds of physical activity) reduce stress.
Another treatment component is family therapy, because the alcoholic's entire support system has been signifi cantly aff ected by the disease. Th e family needs to become educated about the illness. Th en there is educational group therapy, in which he learns about the disease of addiction and the triggers that set it off . AA, a sober peer support system, is still another important part of the comprehensive approach. It is one of the talking therapies, which can be either one-on-one or in a group format to focus on the alcoholic's personal issues. Th e 12-step program of AA helps to reconnect the alcoholic with people who are healthy and sober. Many active alcoholics hang out only with other alcoholics, because people who aren't alcoholics tend to shy away from them and their erratic behaviors, but other alcoholics can put up with them because they are intoxicated too. AA can help break this cycle and reestablish a healthy support system.
As you can see, this science-based, comprehensive approach to treating addiction is truly multidimensional, similar to disease management programs for diabetes, heart disease, or asthma. For successful long-term sobriety from alcohol and drugs, the science-based, comprehensive approach to treatment is crucial.
Roberts: What have you built to accomplish this comprehensive approach?
Urschel: We've built Enterhealth, an addiction disease management company translating bench science into bedside care here in Dallas. It has three primary treatment components: a world-class residential addiction treatment center of excellence, an outpatient addiction treatment center of excellence, and a very innovative and robust Internet-based addiction treatment connectivity platform. Together, these three components provide a complete continuum of care for addiction treatment. Th e real benefi t of treatment for a patient/family within the Enterhealth continuum of care is that it is a "one-stop shop" with all the science-based resources in one place. Our goal for Enterhealth is to manage the disease of addiction successfully over the life span of an individual, doing research and training as we go along. Th e outpatient addiction treatment center of excellence is located in Preston Center. 
Roberts: How often do patients have to go for visits?
Urschel: It depends. Every patient has a customized program. Usually at the beginning of treatment, patients and their family members come much more frequently, but it depends on the severity of the alcohol/drug addiction. Withdrawal stabilization (detox) requires coming every day for about a week, then 2 to 4 times a week for medication/therapy visits for a week or two, followed by less frequent visits. In the meantime, patients are going to AA meetings, restarting an exercise program, reengaging with their church or religious institution, and going back to work-it's a full schedule. Remember, the brain is injured, so it is not quite as easy to do it successfully without the use of some of the antiaddiction medications, which help patients heal or at least begin to reengage their brain.
Roberts: What are these antiaddiction drugs, and how long have they been available? Who gets them, and how are they taken?
Urschel: Th e antiaddiction medications for alcohol have been around for a long time. Th e fi rst one was Antabuse (disulfi ram), the one that makes you sick if you drink alcohol. It's a fourthline treatment now, only for very specialized circumstances. Th e primary one we use is Vivitrol (extended-release naltrexone), an injectable, oral naltrexone, and Campral (acamprosate). Th e Prometa protocol is another. Every alcoholic who comes into our practice will be a likely candidate for some combination of these medicines. Th ey are not "silver bullets" by themselves, but they are important components of the comprehensive approach, because they all aff ect the chemistry of the injured brain, but in diff erent ways.
Most candidates will be given Vivitrol and Campral at the same time. Vivitrol is an extended-release form of naltrexone (opiate antagonist), a medication that has been around since the 1950s, originally approved for opiate (narcotic) addiction. In 1994, the oral naltrexone was also approved for alcoholism. Related to naltrexone, a shorter-acting opiate antagonist, Narcan (naloxone), is used to reverse opiate overdoses, especially in the emergency setting. In 2006, Vivitrol was approved to treat alcoholism and is a much superior form to the oral dose. Naltrexone does three things for the alcoholic within 3 days of initiation: 1) it decreases the urge to use alcohol (i.e., cravings) by up to 90%; 2) it blocks the eff ects of alcohol such that one is not able to get drunk; and 3) it decreases the severity of a relapse. Th e problem with the oral medication is that if it is not taken, it doesn't work. In alcoholism, the brain is injured so it's hard to remember to take medicines; therein lies the tremendous benefi t of Vivitrol, a once-a-month injection that removes the issue of medication compliance for the entire month. Additionally, the oral dosage of naltrexone is 50 mg/ day, so for 1 month that is 1500 mg. Th e intramuscular dose is only 380 mg a month. It's less than a fourth of the oral dosage, and it has fewer side eff ects because when it is injected into the gluteal muscle, it bypasses the fi rst pass hepatic eff ect, so less is needed to achieve 4 times the brain levels of the oral dose because it bypasses the liver.
Vivitrol is my fi rst choice for all alcoholics entering the Enterhealth system; my second choice is Campral. When Vivitrol enters the brain, it doesn't heal the brain; it sits on the receptors inertly. Once the alcohol stops being fed into the brain and causing injury, the brain starts healing again. Th e healing process for an alcoholic brain takes at least 4 to 12 months.
Roberts: This is without any alcohol at all during that period-complete sobriety?
Urschel: Yes. People ask why the time range for healing-4 to 12 months-is so long. Diff erent levels of alcohol use and resulting brain trauma take diff erent amounts of time to heal. Also, many alcoholics use drugs as well, and the combinations of both categories can be synergistically toxic at times. During that 4-to 12-month healing time, the patient's cognitive and multitasking abilities improve. So look at Vivitrol as keeping the alcohol out, and the brain can heal on its own. Campral's benefi cial eff ects, in contrast, are not felt for 4 to 8 weeks after it is started. We think it reboots a certain neurotransmitter system called GABA, which helps the alcoholic begin to calm down. Th at system is injured specifi cally by alcohol and stimulants. Campral is like an antidepressant; by rebooting the system, the brain heals in less time.
When I left St. Paul Hospital and went into practice in 2004, I simultaneously started a company called CNS Research Group, which focused on looking for new medications-phase III and IV clinical trials-for alcohol and drug addiction and for psychiatric disorders. During this time, I was principal investigator on some multisite clinical trials testing several antiaddiction medications before they were approved by the Food and Drug Administration. My fellowship at Pennsylvania specifi cally addressed how to do clinical research trials, and doing them of course increased my scientifi c credibility because they resulted in publications in peer-reviewed journals.
For one of these trials, the drug treatment Prometa was brought to me as a possible new approach to treating patients with methamphetamine addiction. Methamphetamine is one of the most toxic substances to the human brain. Methamphetamine addiction causes lack of focus and loss of short-term memory, so it is hard for meth addicts to stay in outpatient treatment, because they lose track of time, their cravings are through the roof, and they just cannot integrate anything they are being taught. I predicted that the Prometa treatment would not work with methamphetamine patients. Nevertheless, we tested the treatment on this population and actually found it to be very eff ective. I had patients who were daily users of meth for 10 years who received this protocol and from day one never used methamphetamine again and were still sober 3 years later. We published the results in the Mayo Clinic Proceedings. Th e article caused tremendous controversy in the addiction fi eld. Some thought the results were too good to be true. We then did a double-blind placebo-controlled trial that replicated the positive findings and was published in the Journal of Psychopharmacology. Prometa treatment unfortunately is not paid for by insurance companies. Although very expensive, the treatment works well for alcohol, cocaine, and methamphetamine addiction. Th e treatment not only removes the craving and the desire to use these three classes of substances, but also seems to reboot cognitive functioning rather quickly, many times within 7 to 12 days of starting the treatment. I am certain that other antiaddiction medications will come along to give more hope to addicted patients and their families.
Roberts Urschel: It's a 45-acre horse ranch. We kept the ranch house but scrapped everything else and built individual cabins, something unique because most residential treatment centers require two patients per room, whereas Enterhealth Ranch has private rooms. Our goal is to have a serene, "hope-producing," optimistic environment that can accelerate the healing process for recovery. Th e ranch takes the 25% most severe patients with alcohol/drug addiction, those who cannot handle the outpatient process. Most treatment programs in the USA allow residents to stay only 28 days, mainly due to the 1990s insurance coverage benefi ts.
At Enterhealth Ranch, just like at our outpatient program, we individualize the treatment plan for each patient. After discharge from the ranch, the residential patients transition back into our offi ce practice because both systems work together and have the same science-based treatment philosophy. Without this continuum of care, when a patient goes from one level of care to another level of care in addiction treatment, frequently the new level of care has a completely diff erent philosophy, the client has to start all over, and the family is frequently excluded from treatment. Th is is another reason for clients and family to use Healing the Addicted Brain as a guidebook for the treatment experience. Reading it allows them to become better educated and better able to look out for the sobriety interests of themselves or their loved ones.
Roberts: How many staff do you have at the inpatient facility?
Urschel: About 40. It's more of a boutique program, so we can customize the treatment. We usually have one therapist (social worker, counselor, or psychologist) for every 5 to 6 patients. Th e actual clinical programming is very similar to the clinical program at the outpatient center, because I was the clinical architect for both programs using the NIH research fi ndings as the foundation for both.
Roberts: Do family members stay at the ranch? Urschel: No. We engage them through onsite visits, video conferencing, and Internet access throughout the week according to the family's availability. Every week on Sundays, we have a group family meeting. Other times family therapy is done at the outpatient clinic or on the Internet. Th rough Enterhealth, I helped to create an Internet delivery platform/website to provide education and treatment for alcohol and drug addiction online over the web. Th e families frequently fi nd this Internet tool very helpful.
Roberts: Th e online address is www.enterhealth.com, then click on "online recovery."
Urschel: Yes. Th e website right now is a great repository of basic information about addiction. It talks about a lot of the information that is in my book. Also, it has e-lessons, online learning modules that cover all the important topics to help learners stay sober, either as a patient or a family member. It's delivered online in an easy-to-learn format and is interactive. Baylor Health Care System (BHCS) bought a license for it for all its employees and their families last year, and it's an insurance benefi t under Aetna and Value Options. Any BHCS employee or their family member can get access at no cost. Th e nice thing about the online product is that it's anonymous. Th ere is still a lot of stigma associated with alcoholism. It's still scary for people.
Roberts: I thought the website was free for anyone. Urschel: Th e website is free, but for the general public, elessons cost $39 a month for unlimited access.
Roberts: It's a substitute in a way for going to the outpatient facility?
Urschel: It's not meant to replace using the treatment facilities but rather to enhance and reinforce the benefi ts of treatment, and it can be used whenever it is convenient.
Roberts: It's a mechanism for explaining the principles of change?
Urschel: Exactly. It helps patients incorporate this new, critical, life-saving information into their life, using the latest principles of e-learning technology. Southern Methodist University will soon start using it for their students and faculty. Several local court systems are beginning to use the www.enterhealth. com program as well, requiring individuals who drive while intoxicated to go through the online program.
Roberts: Th e Enterhealth Ranch seems to be a pleasant place. Th e residents have an opportunity to meet others struggling with the same issues. Do you have to have money to go to the in-house facility?
Urschel: Yes, we are a private-pay facility. We are out of network with insurance plans, because they require one to leave by a certain day, and insurance also dictates what you can and cannot do-what medicines you can take, for example. Of people with insurance, 62% do not use it for alcohol and drug addiction treatment because they don't want it to go on their record-job, licensing board, etc. So, even if they have insurance they would rather pay cash. We do help them apply for their insurance, if they wish, and they usually get between 50% and 75% of their cost for the Enterhealth program paid back by their insurance companies. Only a minority don't apply for reimbursement. We also have scholarships available. In 2009, we provided scholarships in the amount of $300,000, and in 2010, a total of $440,000. We raise money in the philanthropic community to provide scholarships. Our goal at Enterhealth is to fi nd ways to help every person that we can.
Roberts: Is this a for-profi t institution? Urschel: Yes. Roberts: How often are you at the ranch? Urschel: I am there about once or twice a week. I also work at the outpatient offi ce and on the Internet project. We have a full-time physician working at the ranch. Whenever some part of our care continuum needs to access me, they can.
Roberts: Is the inpatient facility usually full? Urschel: Yes, our census averages about 23 patients at any one time for the 26 available beds.
Roberts: Your program is the only one in the Dallas-Fort Worth area?
Urschel: Ours is the only science-based continuum of care in probably the entire state of Texas, unfortunately. I wish we had 50 competent competitors, because we can only help 26 people at a time at the residential facility and 80 to 100 per week at the outpatient program. Th e program works. Alcoholics and drug addicts who have failed in multiple other addiction treatment programs have succeeded in ours.
Roberts: It took a lot of resources to get this program going. Have you been pleased with the success of it?
Urschel: Yes. We opened the doors to the Enterhealth Ranch in December 2008 just as the recession hit. We have been blessed with insightful and supportive investors, who have taken this project to heart as well as making it a thriving business. Most critical to Enterhealth's success on the investor/business side are David Kniff en Sr. and David Kniff en Jr. Without their tremendous expertise and support, Enterhealth would not be serving the Dallas-Fort Worth communities so eff ectively. It is very rare to fi nd seasoned business professionals who are so committed to building a specialty health care system that truly focuses on patient quality of care as the number one priority of the organization. Th e Kniff ens are two of those rare people.
Roberts: What is your life like outside of your medical endeavors? What time do you get home at night?
Urschel: I get home by 5:30 pm. I usually get up around 4:45 am. I work out in the morning and then help Christi get the kids ready for the day. I take Carr to school around 7:30 am. Once we get the kids to bed, Christi and I often work on diff erent projects. Enterhealth is my main project here in Dallas, but I am also trying to market its message of hope and science-based breakthroughs for addiction treatment all across the country. I don't use marketing in a negative way. Th is is life-saving information; the American public has to know that there is a better way to get and stay sober than just through traditional addiction treatment programs. It takes a lot of time to get the message out-radio and TV interviews, articles to write, etc.
Roberts: How many alcoholics are in the Dallas-Fort Worth area?
Urschel: Th ere are 7 million people in the area. If there was a 10% incidence, there would be 700,000 alcoholics; if a 5% incidence, 350,000 alcoholics. Th rough Enterhealth alone, we can treat 26 residents at the ranch at any one time and 100 outpatients per week in our practice. Th ere are also six other addiction practices in the area. All together, about 15,000 to 20,000 alcoholics are treated each year in this area. As you can see, we are not even beginning to scratch the surface of the problem in Dallas-Fort Worth.
In the entire USA, the situation is just as bleak, where 21 million are either alcohol abusers (prealcoholism) or alcoholics (alcohol dependence) (2003 data). Of the 21 million, about 9 million have alcohol dependence. Of the 9 million alcohol addicts, only 2.2 million are in treatment, and that includes all those in AA's 12-step program. Th us, at least three quarters (if not a lot more) of the confi rmed alcoholics in this country aren't even in treatment yet. Even more concerning is the fact that of the 2.2 million alcoholics in treatment, only about 300,000 are getting antiaddiction medications.
Th e reason I wrote Healing the Addicted Brain was to get the information we have been discussing organized and into one easily accessible place. Has anything that I've told you today been hard to understand? No, not one thing. Treating addiction eff ectively is not rocket science! My book was meant to help educate the general public because treatment providers are not changing their "old-fashioned" ways of treating addiction. My wife pushed me to write the book, which took me 3 years. My goal through both the book and Enterhealth is to create a better-educated consumer and have them "pull" the addiction treatment industry in the US into the 21st century. Most alcoholics don't want treatment because either they do not think they have a problem or their physicians are not diagnosing the illness and confronting them with the latest science-based treatment strategies or referrals.
Except for one outpatient program in Fort Worth, BHCS does not have an addiction treatment center. For premier medical systems not to be able to eff ectively address the third major cause of death in the US is not acceptable. However, BHCS is not alone. Th ere is no addiction treatment program at UT Southwestern Medical School, which has more Nobel laureates than any other medical school in the country and has 7 or 8 square city blocks of the best research out there. Next to it is Parkland Hospital, a large county hospital covering 5 square blocks. Th ere is not a single addiction treatment program to treat this third leading cause of death in the US in this 13 cityblock medical center area. How crazy is that situation? Methodist Hospitals only have one addiction treatment program. Presbyterian Hospitals actually do a pretty good job-the best one in the city right now for addiction treatment. Th ey are still not there in the science-based model, but they are a lot closer than all of the others.
My book hopefully is also a resource for physicians and others to learn more about addiction. Physicians don't have time to educate all their patients about everything we've been talking about. Th eir nurses can learn from the book, and the book can educate both the patients and their families. Th e primary care physicians don't have to have the burden of treating alcohol/ drug addiction; they need to have the burden of identifying it and referring the patient/family to the appropriate resources to access the science-based treatment model. Also, the book is closely integrated to the e-lessons on Enterhealth. Th e readers are sent to the e-lessons 13 diff erent times throughout the book. So the book, through the website, can get addicts connected with the right treatment resources, which most physicians have no knowledge about. By the way, primary care physicians who diagnose alcoholism can give Vivitrol as one component of a comprehensive treatment approach for that specifi c addicted patient. Vivitrol is paid for by insurance, and it's very eff ective.
Roberts: How much do the antiaddiction medications cost?
Urschel: Vivitrol in the private sector costs $900 per month. It's completely covered by private insurance. In the Medicaid sector, it's $500 per month. To my knowledge, Medicare doesn't pay for outpatient treatment or for antiaddiction medicines.
Roberts: Are there more alcoholics under age 65 or over 65? Urschel: More under 65. Th e peak time for active alcoholism is between 25 and 50 years. Nevertheless, alcoholism and prescription drug addiction is a huge problem in the elderly, especially in retirement homes, where depression and insomnia lead to self-medication with multiple meds. Retirement years can reinitiate alcoholism and depression, especially because of boredom and loss of friends. Th at older group is treated with the same comprehensive approach as the younger alcoholics.
Roberts: Th ere is a lot of discussion regarding marijuana, whether it should be legalized or not. What's your view?
Urschel: Marijuana should not be legalized! If you had the opportunity to legalize cigarettes now, knowing what you know about them, would you legalize cigarettes? Absolutely not. Marijuana is addicting! Th e frequency of marijuana addiction is 7% to 10%, the same as alcohol. Marijuana has 250 substances in the smoke. THC, which gives you the high, is only one of those substances. People smoke it to get the THC into their blood system. We do not know what the other 249 substances are because they vary depending on what pesticides (chemicals) are used to grow the marijuana and what it is dipped in to give a better eff ect. All that stuff is aerosolized, sent into your lungs, and shot straight to the brain. Th e smoke of marijuana is four times more carcinogenic than normal cigarette smoke. And, persons smoking marijuana hold the smoke in their lungs to get better absorption of the THC, giving additional time for the higher percentage of carcinogens to cause more cancer. Nobody talks about that side of marijuana! we had kids, we took a lot of trips, including climbing to the base camp of Mount Everest. We are outdoorsy active people.
Roberts: What kind of exercise do you do? Urschel: I do about an hour of aerobic activity 4 times a week. I use the horizontal elliptical and the recumbent bicycle. I also do a lot of weight lifting, core training, and fl exibility exercises.
Roberts: Do you read a lot? Urschel: No. I write a lot. I am very busy speaking and trying to build the Enterhealth continuum and take its messages and technology all across the country so millions of Americans with addiction can start to truly get better.
Roberts: How many talks do you give a year?
Urschel: About 50 to 60. Roberts: How often do you travel a year? Urschel: I try not to travel too much because of Chance. When I'm gone, it is harder on Christi to handle him alone. I usually travel once a month and then for only 2 nights.
Roberts: Is there anything you'd like to talk about that we haven't touched on yet?
Urschel: Yes. Th e family of the alcoholic is key to the alcoholic's recovery. Maybe the "family" is a partner or group of friends. Th e entire support system has been aff ected by the illness. Th e alcoholic's brain is injured, which in turn makes learning all the things needed to stay sober harder. Th e family can really help in this regard. In Healing the Addicted Brain and in our treatment programs, I target the family and show them the game plan of how to treat this illness. Unfortunately, they have nowhere else to go-no minister, physician, or local treatment program or sponsor. None of those people are going to give them access to a comprehensive, NIH-based treatment plan. Consequently, the family needs to be able to create the game plan and help the alcoholic implement it. Th ere are a lot of other programs out there, but they have only small pieces of the puzzle. Th e benefi t of the website and the book is that they give the family and support system the direction they need to take the puzzle pieces from several diff erent sources and create a successful plan.
Roberts: Hal, thank you. 
